Impact of a reduced nicotine standard on young adult appeal for menthol and non-menthol cigarettes

Author:

Cohn Amy MORCID,Cassidy Rachel,Denlinger-Apte Rachel,Donny Eric,Villanti Andrea CORCID,Hatsukami Dorothy,Dunn Delaney,Wyatt Riley,Niznik Taylor,Cohen-Davidyan Tamar,Smith Michael,Ehlke Sarah J

Abstract

IntroductionThe Food and Drug Administration (FDA) announced its intention to reduce the nicotine content in cigarettes as a strategy to promote cessation and reduce smoking-related harm. A low nicotine product standard will apply to all cigarettes on the market, including menthol cigarettes. In December 2021, the FDA approved a modified risk tobacco product application for menthol and non-menthol flavoured very low nicotine cigarettes (VLNC) from the 22nd Century Group. Notably, experimentation with menthol cigarettes is linked to smoking progression, as well as greater nicotine dependence relative to non-menthol cigarette use. If menthol VLNCs are perceived as more appealing than non-menthol VLNCs, this would indicate that some aspect of menthol may maintain smoking even in the absence of nicotine and FDA’s regulatory authority to ban or restrict the sale of menthol cigarettes should apply to reduced nicotine content of cigarettes. In April 2022, the FDA announced proposed rulemaking to prohibit menthol cigarettes, however it is unclear if a menthol prohibition would apply to VLNCs.Methods and analysisThis study will recruit 172 young adult menthol smokers (with a specific subsample of n=40 sexual and gender minority young adults) and measure appeal for smoking experimental menthol and non-menthol VLNCs, and the impact of proposed product standards on tobacco product purchasing behaviour using an Experimental Tobacco Marketplace. Appeal across product standards will be assessed in a controlled laboratory and using ecological momentary assessment.Ethics and disseminationThe protocol was approved by the University of Oklahoma Health Sciences Center Institutional Review Board (#11865). Findings will examine the effects of a reduced nicotine standard and a menthol ban on young adult smoking and will be disseminated through peer-reviewed journal articles and presentations at scientific conferences.Trial registration numberNCT04340947.

Funder

National Institute on Drug Abuse

Center for Tobacco Products

Publisher

BMJ

Subject

General Medicine

Reference50 articles.

1. FDA authorized marketing of tobacco products that help reduce exposure to and consumption of nicotine for smokers who use them, 2021. Available: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-tobacco-products-help-reduce-exposure-and-consumption-nicotine-smokers-who [Accessed 16 Aug 2022].

2. Department of Health and Human Services, Food and Drug Administration . Tobacco product standard for nicotine level of combusted cigarettes. 83, 2018.

3. Reducing nicotine in cigarettes to minimally addictive levels: a new frontier for tobacco control;Hatsukami;JAMA Psychiatry,2018

4. Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial;Hatsukami;Addiction,2017

5. Assessment of menthol and Nonmenthol cigarette consumption in the US, 2000 to 2018;Delnevo;JAMA Netw Open,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3